Vor Biopharma Inc.VOR stock score: 43/100

$18.52 · +3.87% · Scored Nov 19, 2026

Technical
44
Fundamental
43
News
51

The reading

Vor Biopharma (VOR) scores 43 out of 100, which reads weak, higher than 30% of Healthcare stocks and 28% of the 4,118 US stocks we score.

The composite weights fundamentals 80% and technicals 20%: fundamentals read 43, technicals 44.

Among the fundamentals, Quick Ratio at 100 and Price Target at 100 score highest, while Free Cash Flow Yield at 0 weighs the most against it.

On the daily chart, trend-following indicators average 38 and contrarian oscillators 61.

News sentiment is neutral at 51; it is shown, not counted in the composite.

Since Aug 23, 2026 the composite has ranged from 35 to 46, and it ends the period where it started.

About Vor Biopharma

Vor Biopharma (VOR), which operates as Vor Bio, is a clinical-stage biotechnology company developing treatments for autoimmune diseases. Its lead product candidate is telitacicept, a fusion protein that blocks two proteins, BLyS and APRIL, which help drive the B cells and plasma cells behind many autoimmune conditions. Vor licensed global rights to telitacicept outside Greater China from RemeGen, which developed the drug and markets it in China for systemic lupus erythematosus, rheumatoid arthritis and generalized myasthenia gravis. Vor is running a global late-stage trial of telitacicept in generalized myasthenia gravis and is exploring other indications. It has also licensed RC298, an early-stage, longer-acting BLyS and APRIL candidate, from RemeGen. The company has no product revenue and funds its research through stock sales, and it owes RemeGen milestone payments and royalties if its drugs succeed.

Vor competes with companies developing treatments for myasthenia gravis and other autoimmune diseases, including argenx, UCB and Johnson & Johnson, as well as Vera Therapeutics, which is developing a drug that targets the same pathway. Its edge rests on a late-stage asset that already has clinical and commercial experience in China and a dual-targeting approach. Investors who follow VOR stock tend to watch results from the global trial of telitacicept and the timing of regulatory filings. Cash runway is closely followed. Plans for additional indications, partnership terms with RemeGen and share dilution are other factors.

What’s driving the score

The strongest and weakest of the scorers that count toward VOR’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.

Fundamental

43

Pulling it up

  • Quick ratio measures a company's ability to meet short-term obligations with liquid assets.

  • Price target score compares the current stock price to analyst consensus targets.

  • Current assets divided by current liabilities: the ability to pay short-term bills.

Holding it back

  • Free cash flow yield is free cash flow divided by market value: the cash a business generates for each dollar of its price.

  • Return on Assets (ROA) shows how efficiently a company uses its assets to generate profit.

  • Net income growth from the prior fiscal year to the latest.

21 weighted scorers; 18 had no data today and are left out rather than counted as zero.

Technical · daily

42

Pulling it up

  • Where the close sits against its 200-day EMA.

  • The price change over the last 52 weeks.

  • Candlestick patterns recognize specific price formations that historically suggest continuation or reversal.

Holding it back

  • Parabolic SAR (Stop and Reverse) provides trailing stop levels that follow price trends.

  • Ichimoku Cloud is a comprehensive indicator showing support/resistance, trend direction, and momentum.

  • Where the close sits against its 100-day SMA.

62 weighted scorers; 3 had no data today and are left out rather than counted as zero.

News · shown, not counted

Global News
51

Technical score by timeframe

ChartScoreWeight
Hourly531
Daily423
Weekly372
Monthly482

Composite score, last 90 days

05010043Aug 23, 2026Nov 19, 2026Aug 23, 2026: 43Aug 24, 2026: 43Aug 25, 2026: 45Aug 26, 2026: 44Aug 27, 2026: 44Aug 28, 2026: 42Aug 29, 2026: 42Aug 30, 2026: 42Aug 31, 2026: 41Sep 1, 2026: 43Sep 2, 2026: 45Sep 3, 2026: 45Sep 4, 2026: 45Sep 5, 2026: 45Sep 6, 2026: 46Sep 7, 2026: 45Sep 8, 2026: 46Sep 9, 2026: 43Sep 10, 2026: 41Sep 11, 2026: 42Sep 12, 2026: 43Sep 13, 2026: 43Sep 14, 2026: 43Sep 15, 2026: 42Sep 16, 2026: 40Sep 17, 2026: 41Sep 18, 2026: 42Sep 19, 2026: 40Sep 20, 2026: 40Sep 21, 2026: 43Sep 22, 2026: 43Sep 23, 2026: 39Sep 24, 2026: 36Sep 25, 2026: 36Sep 26, 2026: 36Sep 27, 2026: 36Sep 28, 2026: 35Sep 29, 2026: 36Sep 30, 2026: 37Oct 1, 2026: 35Oct 2, 2026: 37Oct 3, 2026: 37Oct 4, 2026: 37Oct 5, 2026: 37Oct 6, 2026: 36Oct 7, 2026: 37Oct 8, 2026: 39Oct 9, 2026: 40Oct 10, 2026: 40Oct 11, 2026: 40Oct 12, 2026: 41Oct 13, 2026: 38Oct 14, 2026: 37Oct 15, 2026: 39Oct 16, 2026: 36Oct 17, 2026: 36Oct 18, 2026: 36Oct 19, 2026: 36Oct 20, 2026: 38Oct 21, 2026: 39Oct 22, 2026: 38Oct 23, 2026: 36Oct 24, 2026: 36Oct 25, 2026: 36Oct 26, 2026: 36Oct 27, 2026: 41Oct 28, 2026: 44Oct 29, 2026: 45Oct 30, 2026: 41Nov 1, 2026: 41Nov 2, 2026: 40Nov 3, 2026: 43Nov 4, 2026: 44Nov 5, 2026: 38Nov 6, 2026: 41Nov 7, 2026: 41Nov 8, 2026: 41Nov 10, 2026: 41Nov 11, 2026: 45Nov 12, 2026: 41Nov 13, 2026: 43Nov 14, 2026: 44Nov 15, 2026: 44Nov 16, 2026: 43Nov 17, 2026: 42Nov 18, 2026: 42Nov 19, 2026: 43
Show the daily numbers
DateComposite
Nov 19, 202643
Nov 18, 202642
Nov 17, 202642
Nov 16, 202643
Nov 15, 202644
Nov 14, 202644
Nov 13, 202643
Nov 12, 202641
Nov 11, 202645
Nov 10, 202641
Nov 8, 202641
Nov 7, 202641
Nov 6, 202641
Nov 5, 202638
Nov 4, 202644
Nov 3, 202643
Nov 2, 202640
Nov 1, 202641
Oct 30, 202641
Oct 29, 202645
Oct 28, 202644
Oct 27, 202641
Oct 26, 202636
Oct 25, 202636
Oct 24, 202636
Oct 23, 202636
Oct 22, 202638
Oct 21, 202639
Oct 20, 202638
Oct 19, 202636
Oct 18, 202636
Oct 17, 202636
Oct 16, 202636
Oct 15, 202639
Oct 14, 202637
Oct 13, 202638
Oct 12, 202641
Oct 11, 202640
Oct 10, 202640
Oct 9, 202640
Oct 8, 202639
Oct 7, 202637
Oct 6, 202636
Oct 5, 202637
Oct 4, 202637
Oct 3, 202637
Oct 2, 202637
Oct 1, 202635
Sep 30, 202637
Sep 29, 202636
Sep 28, 202635
Sep 27, 202636
Sep 26, 202636
Sep 25, 202636
Sep 24, 202636
Sep 23, 202639
Sep 22, 202643
Sep 21, 202643
Sep 20, 202640
Sep 19, 202640
Sep 18, 202642
Sep 17, 202641
Sep 16, 202640
Sep 15, 202642
Sep 14, 202643
Sep 13, 202643
Sep 12, 202643
Sep 11, 202642
Sep 10, 202641
Sep 9, 202643
Sep 8, 202646
Sep 7, 202645
Sep 6, 202646
Sep 5, 202645
Sep 4, 202645
Sep 3, 202645
Sep 2, 202645
Sep 1, 202643
Aug 31, 202641
Aug 30, 202642
Aug 29, 202642
Aug 28, 202642
Aug 27, 202644
Aug 26, 202644
Aug 25, 202645
Aug 24, 202643
Aug 23, 202643

Key facts

Market cap
$1.1B
Sector
Healthcare
Industry
Biotechnology
Beta
1.83
Risk grade (1–10)
10
Next earnings
Oct 30, 2026

Questions

What is VOR's stock rating today?

VOR scores 43/100 (Weak) as of Nov 19, 2026: technical 44, fundamental 43, and news sentiment 51, which is shown but not counted. Scores are recomputed every night.

What does Vor Biopharma do?

Vor Biopharma (VOR), which operates as Vor Bio, is a clinical-stage biotechnology company developing treatments for autoimmune diseases. Its lead product candidate is telitacicept, a fusion protein that blocks two proteins, BLyS and APRIL, which help drive the B cells and plasma cells behind many autoimmune conditions.

Is VOR stock a buy?

The score is not a buy or sell recommendation. A 43 says the technical and fundamental signals we measure lean weak today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.

How is the VOR score calculated?

83 weighted scorers feed it today: 21 fundamental, scored against Healthcare ranges, and 62 technical on the daily chart, with 4 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.

Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.

Embed this score

A badge for a blog post, newsletter or README. It updates every night and links back here. More badges

VOR stock score

HTML

<a href="https://stocksscores.com/stocks/vor/"><img src="https://stocksscores.com/stocks/vor/badge.svg" alt="VOR stock score" height="20"></a>

Markdown

[![VOR stock score](https://stocksscores.com/stocks/vor/badge.svg)](https://stocksscores.com/stocks/vor/)